Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 4076 - 4100 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Gangliosides LMSP0601CN02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262469 1707.929487 C79H141N3O36
Gangliosides LMSP0601DV02
  • NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262717 1707.929487 C79H141N3O36
Gangliosides LMSP0601EU02
  • NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262909 1707.929487 C79H141N3O36
Gangliosides LMSP0601GK02
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263205 1707.929487 C79H141N3O36
Gangliosides LMSP0601GL02
  • NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263213 1707.929487 C79H141N3O36
Gangliosides LMSP0601GS02
  • Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263261 1707.929487 C79H141N3O36
Gangliosides LMSP0601GW02
  • NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44263293 1707.929487 C79H141N3O36
Gangliosides LMSP0601AF02
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262005 1723.924402 C79H141N3O37
Diacylglycerophosphoinositolglycans LMGP15010247
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/18:1(9Z))
126457615 1808.858433 C79H141O43P
Diacylglycerophosphoinositolglycans LMGP15010256
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:0/16:1(9Z))
126457624 1808.858433 C79H141O43P
Diacylglycerophosphoinositolglycans LMGP15010261
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:1(9Z)/16:0)
126457629 1808.858433 C79H141O43P
Gangliosides LMSP0601DD08
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262587 1614.959663 C79H142N2O31
Gangliosides LMSP0601DF08
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • KDN-GM1(d18:1/26:1(17Z))
44262603 1614.959663 C79H142N2O31
Gangliosides LMSP0601EB08
  • KDN-lactotetraosylceramide(d18:1/26:1(17Z))
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262763 1614.959663 C79H142N2O31
Gangliosides LMSP0601EC08
  • KDN(2-6)lactotetraosylceramide(d18:1/26:1(17Z))
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262771 1614.959663 C79H142N2O31
Gangliosides LMSP0601GE08
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263171 1614.959663 C79H142N2O31
Gangliosides LMSP0601GG08
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/26:1(17Z))
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263187 1614.959663 C79H142N2O31
Gangliosides LMSP0601GF03
  • KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263174 1678.939323 C79H142N2O35
Gangliosides LMSP0601AH05
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262024 1629.970562 C79H143N3O31
Gangliosides LMSP0601AP05
  • GM1(d18:1/24:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262088 84671 1629.970562 C79H143N3O31
Gangliosides LMSP0601AY05
  • GM1b(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262160 1629.970562 C79H143N3O31
Gangliosides LMSP0601BM05
  • GM1alpha(d18:1/24:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262272 1629.970562 C79H143N3O31
Gangliosides LMSP0601DK05
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl-lactotetraosylceramide(d18:1/24:0)
44262632 1629.970562 C79H143N3O31
Gangliosides LMSP0601DY05
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl(2-6)lactotetraosylceramide(d18:1/24:0)
44262736 1629.970562 C79H143N3O31
Gangliosides LMSP0601DZ05
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262744 1629.970562 C79H143N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024